Vycor Medical VYCO
OTC VYCO
$0.07 +0.01 (+22.63%)
At close: Aug 19, 2026 · 12:49 PM UTC

Vycor Medical (VYCO) Restructuring Costs (2012)

Vycor Medical (VYCO) posted quarterly Restructuring Costs of $18285.0 for Q1 2012.

Vycor Medical (VYCO) Restructuring Costs (2012) Analysis & Trends

Vycor Medical (VYCO) has reported Restructuring Costs for 1 consecutive years, with $18285.0 the latest figure, recorded in Q1 2012.

  • In Q1 2012, Restructuring Costs changed N/A year-over-year to $18285.0; the TTM figure through Dec 2012 stood at $18285.0 (changed N/A YoY), while the FY2012 annual figure was $18285.0, down 83.38% from the prior year.
  • Restructuring Costs was little changed at $18285.0 in Q1 2012 per VYCO's latest filing.
  • Across five years, Restructuring Costs topped out at $18285.0 in Q1 2012 and bottomed at $18285.0 in Q1 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 Vycor Medical 2.34 Mn 2.18 Mn 344,445.00

Historic Data

Download Data
DateValue
Mar 31, 2012 18,285.00